The store will not work correctly when cookies are disabled.
N-[(3,5-ditert-butyl-4-oxo-cyclohexa-2,5-dien-1-ylidene)amino]-4-nitro-benzamide
ID: ALA4571126
PubChem CID: 5033896
Max Phase: Preclinical
Molecular Formula: C21H25N3O4
Molecular Weight: 383.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)C1=CC(=NNC(=O)c2ccc([N+](=O)[O-])cc2)C=C(C(C)(C)C)C1=O
Standard InChI: InChI=1S/C21H25N3O4/c1-20(2,3)16-11-14(12-17(18(16)25)21(4,5)6)22-23-19(26)13-7-9-15(10-8-13)24(27)28/h7-12H,1-6H3,(H,23,26)
Standard InChI Key: PBOAPRYWMUBZEJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
35.0616 -11.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7735 -11.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4812 -11.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4812 -12.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7735 -13.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0616 -12.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7735 -13.8503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0619 -14.2618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.3545 -13.8503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6471 -14.2618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6467 -15.0806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9377 -15.4852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2299 -15.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2277 -14.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9353 -13.8478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5225 -15.4850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8151 -15.0777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5225 -16.3037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3545 -13.0316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.1887 -11.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1887 -10.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9003 -11.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9003 -10.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7735 -10.5747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3542 -11.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6468 -11.8050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3542 -10.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6468 -10.9863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 1 0
1 6 2 0
5 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
16 13 1 0
16 17 1 0
16 18 2 0
9 19 2 0
3 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
2 24 2 0
1 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
M CHG 2 16 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 383.45 | Molecular Weight (Monoisotopic): 383.1845 | AlogP: 4.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 101.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.49 | CX Basic pKa: 1.43 | CX LogP: 5.10 | CX LogD: 5.09 |
Aromatic Rings: 1 | Heavy Atoms: 28 | QED Weighted: 0.48 | Np Likeness Score: -0.92 |